Bovine Respiratory Disease Treatment Market (Treatment Type - Vaccines, Antibiotics, NSAIDs, and Immunomodulators; Disease Type - Upper Respiratory Tract Infections, Pneumonia (Lower Respiratory Tract Infection), and Diphtheria; Distribution Channel - Veterinary Hospitals, Veterinary Clinics, Private Veterinary Pharmacies, and Veterinary Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024
Bovine Respiratory Disease Treatment Market: Snapshot
Lately, there is surge in the demand for beef meat as human population is increasingly relying on beef to meet their protein requirement. However, consumption of beef meat sourced from cattle with bovine respiratory diseases can severely impact the health of human population.
Meanwhile, bovine respiratory disease occurs due to multiple factors. Some of the factors include- shipping, weaning, weather, nutrition, mixing cattle among multiple sources, and respiratory viruses (BRSV, IBR, PI3, and BVD). Usually, the disease occurs frequently in the beef of calves between 70-170 days old, and it is communicable in nature.
The disease is captivating much attention in recent years as it is impacting the beef industry globally. In order to reduce the negative impact of bovine respiratory disease on entire beef industry, effective prevention measures and treatment is required.
Owing to the revenue being spent on bovine disease treatment globally, the bovine respiratory disease treatment market is projected to grow in coming years. As per the research report published by Transparency Market Research, the bovine respiratory disease treatment is likely to advance at a CAGR of 7.6% in between 2016 and 2024. The market value will reach to US$1543.9 mn by 2024.
Pulmonary Care and Preventive Measures Fuelling Advancement in Treatment Procedures
There are multiple treatment options available for bovine respiratory diseases around the globe. Also, research is going on for the advanced treatment of bovine respiratory disease. This factor is most likely to contribute to the stellar growth of global bovine respiratory disease treatment market.
On the other hand, over the counter medication may cause severe side effects on the affected cattle. As a result of this, the market may experience hindrance in the growth of bovine respiratory disease treatment market. However, ongoing change in pattern the cattle care along with emphasis on pulmonary carry is most likely to fuel the expansion of global bovine respiratory disease treatment market.
On the basis of healthcare center, veterinary hospitals is likely to hold prominence in the expansion of global bovine respiratory disease treatment market. This is because veterinary hospitals have various treatment provision and procedures can be carried out easily under one roof. Veterinary clinics allow one-to-one attention, hence, provides extensive procedure options for the treatment of bovine respiratory diseases. Further, veterinary pharmacies have substantial growth potential owing to the rising demand for drugs for both prevention and treatment of bovine disease. This segment is likely to grow steadily in global bovine respiratory disease treatment market.
Inclination Towards Consumption of Meat Demanding Better Treatment Options
North America has major share in the growth of global bovine respiratory disease treatment market, wherein the U.S. contributes 90% alone. The bovine respiratory disease treatment market is expanding because of increasing in-house production as well as excess consumption of bovine meat in the region. Also, the U.S. is also into the export business of bovine meat.
In spite of huge number of players in the bovine respiratory disease treatment market, the business landscape is a consolidated one. As a result, there is a high degree of competition in the market. Some of the prominent players in the bovine respiratory disease treatment market space are- Merck & Co., Bayer AG, Boehringer Ingelheim GmbH, Virbac Group, Elanco, Bimeda Animal Health, Zoetis Services LLC, Merial, Vetoquinol, and Ceva.
Bovine Respiratory Disease Treatment Market to Gain Impetus from Increasing Cases of respiratory Disorders
There is flood in the interest for hamburger meat as human populace is progressively depending on meat to meet their protein prerequisite. Be that as it may, utilization of hamburger meat sourced from cows with bovine respiratory illnesses can seriously affect the strength of human populace. Additionally, bovine respiratory infection happens because of numerous elements. A portion of the variables incorporate delivery, weaning, climate, nourishment, blending dairy cattle among different sources, and respiratory infections like BVD, BRSV, IBR, and PI3. Generally, the infection happens often in the hamburger of calves between 70-170 days old, and it is transmittable in nature. The illness is enamoring a lot of consideration as of late as it is affecting the hamburger business around the world. To decrease the adverse consequence of bovine respiratory sickness on whole meat industry, compelling anticipation measures and therapy is required. Attributable to the income being spent on bovine infection treatment internationally, the bovine respiratory illness treatment market is projected to fill in the coming years.
The field of pneumonic medicines has acquired footing across the globe as of late. This factor is projected to get voluminous incomes into the worldwide bovine respiratory infection treatment market in the years to come. Moreover, patients experiencing bovine respiratory illness are at a danger of obtaining a few different sicknesses and issues. This factor has additionally assumed a critical part in the development of the worldwide bovine respiratory sickness therapy market. Additionally, the enormous measures of cash spend on medical care and sickness therapy across the world has likewise given a stimulus to the development of the worldwide bovine respiratory infection therapy market.
There are various treatment alternatives accessible for bovine respiratory illnesses all throughout the planet. Additionally, research is continuing for the high level treatment of bovine respiratory sickness. This factor is destined to add to the heavenly development of worldwide bovine respiratory infection treatment market.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bovine Respiratory Disease Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Bovine Respiratory Disease Treatment Market Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global Bovine Respiratory Disease Treatment Market Analysis and Forecasts, 2014 – 2024
4.4.1. Pricing - Actuals and Projections, 2014 – 2024 (US$)
4.4.2. Market Revenue Projections (US$ Mn)
4.5. Bovine Respiratory Disease Treatment Market - Global Supply Demand Scenario
4.6. Porter’s Five Force Analysis
4.7. Value Chain Analysis
4.7.1. List of active market participants (suppliers/distributors/manufacturers/vendors)
4.7.1.1. Product Manufacturers
4.7.1.2. Product Distributors
4.8. Market Outlook
5. Global Bovine Respiratory Disease Treatment Market Analysis and Forecast, Disease Type
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Size (US$ Mn) Forecast, Disease Type,
5.4.1.1. Upper Respiratory Tract Infections
5.4.1.2. Diphtheria
5.4.1.3. Pneumonia (Lower Respiratory Tract Infection)
5.5. Product Comparison Matrix
5.6. Market Attractiveness, Disease Type , 2015
6. Global Bovine Respiratory Disease Treatment Market Analysis and Forecast, Treatment Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Size (US$ Mn) Forecast, Treatment Type,
6.4.1. Vaccines
6.4.2. Antibiotics
6.4.3. NSAIDs
6.4.4. Immunomodulators
6.4.5. Others
6.5. Product Comparison Matrix
6.6. Market Attractiveness, Treatment Type , 2015
7. Global Bovine Respiratory Disease Treatment Market Analysis and Forecast, By Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Key Trends
7.4. Market Size (US$ Mn) Forecast, By Distribution Channel,
7.4.1. Veterinary Hospitals
7.4.2. Veterinary Clinics
7.4.3. Private Veterinary Pharmacies
7.4.4. Veterinary Research Institutes
7.4.5. Others
7.5. Market Attractiveness, By Distribution Channel, 2015
8. Global Bovine Respiratory Disease Treatment Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Policies and Regulations
8.3. Market Size (US$ Mn) Forecast By Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East and Africa
8.4. Market Attractiveness By Country/Region
9. North America Bovine Respiratory Disease Treatment Market Analysis and Forecast
9.1. Key Findings
9.2. Policies and Regulations
9.3. Market Size (US$ Mn) Forecast, Disease Type,
9.3.1. Upper Respiratory Tract Infections
9.3.2. Diphtheria
9.3.3. Pneumonia (Lower Respiratory Tract Infection)
9.4. Market Size (US$ Mn) Forecast, Treatment Type,
9.4.1. Vaccines
9.4.2. Antibiotics
9.4.3. NSAIDs
9.4.4. Immunomodulators
9.4.5. Others
9.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
9.5.1. Veterinary Hospitals
9.5.2. Veterinary Clinics
9.5.3. Private Veterinary Pharmacies
9.5.4. Veterinary Research Institutes
9.5.5. Others
9.6. Market Size (US$ Mn) Forecast, By Country
9.6.1. US
9.6.2. Canada
9.7. Market Attractiveness Analysis
9.7.1. By Country
9.7.2. Disease Type
9.7.3. By Treatment Type
9.7.4. By Distribution Channel
10. Europe Bovine Respiratory Disease Treatment Market Analysis and Forecast
10.1. Key Findings
10.2. Policies and Regulations
10.3. Market Size (US$ Mn) Forecast, Disease Type,
10.3.1. Upper Respiratory Tract Infections
10.3.2. Diphtheria
10.3.3. Pneumonia (Lower Respiratory Tract Infection)
10.4. Market Size (US$ Mn) Forecast, Treatment Type,
10.4.1. Vaccines
10.4.2. Antibiotics
10.4.3. NSAIDs
10.4.4. Immunomodulators
10.4.5. Others
10.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
10.5.1. Veterinary Hospitals
10.5.2. Veterinary Clinics
10.5.3. Private Veterinary Pharmacies
10.5.4. Veterinary Research Institutes
10.5.5. Others
10.6. Market Size (US$ Mn) Forecast, By Country
10.6.1. Germany
10.6.2. UK
10.6.3. Spain
10.6.4. France
10.6.5. Italy
10.6.6. Rest of Europe
10.7. Market Attractiveness Analysis
10.7.1. By Country
10.7.2. Disease Type
10.7.3. By Treatment Type
10.7.4. By Distribution Channel
11. Asia Pacific Bovine Respiratory Disease Treatment Market Analysis and Forecast
11.1. Key Findings
11.2. Policies and Regulations
11.3. Market Size (US$ Mn) Forecast, Disease Type,
11.3.1. Upper Respiratory Tract Infections
11.3.2. Diphtheria
11.3.3. Pneumonia (Lower Respiratory Tract Infection)
11.4. Market Size (US$ Mn) Forecast, Treatment Type,
11.4.1. Vaccines
11.4.2. Antibiotics
11.4.3. NSAIDs
11.4.4. Immunomodulators
11.4.5. Others
11.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
11.5.1. Veterinary Hospitals
11.5.2. Veterinary Clinics
11.5.3. Private Veterinary Pharmacies
11.5.4. Veterinary Research Institutes
11.5.5. Others
11.6. Market Size (US$ Mn) Forecast, By Country
11.6.1. India
11.6.2. China
11.6.3. Japan
11.6.4. Australia
11.6.5. Rest of APAC
11.7. Market Attractiveness Analysis
11.7.1. By Country
11.7.2. Disease Type
11.7.3. By Treatment Type
11.7.4. By Distribution Channel
12. Latin America Bovine Respiratory Disease Treatment Market Analysis and Forecast
12.1. Key Findings
12.2. Policies and Regulations
12.3. Market Size (US$ Mn) Forecast, Disease Type,
12.3.1. Upper Respiratory Tract Infections
12.3.2. Diphtheria
12.3.3. Pneumonia (Lower Respiratory Tract Infection)
12.4. Market Size (US$ Mn) Forecast, Treatment Type,
12.4.1. Vaccines
12.4.2. Antibiotics
12.4.3. NSAIDs
12.4.4. Immunomodulators
12.4.5. Others
12.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
12.5.1. Veterinary Hospitals
12.5.2. Veterinary Clinics
12.5.3. Private Veterinary Pharmacies
12.5.4. Veterinary Research Institutes
12.5.5. Others
12.6. Market Size (US$ Mn) Forecast, By Country
12.6.1. Brazil
12.6.2. Mexico
12.6.3. Rest of LATAM
12.7. Market Attractiveness Analysis
12.7.1. By Country
12.7.2. Disease Type
12.7.3. By Treatment Type
12.7.4. By Distribution Channel
13. Middle East and Africa Bovine Respiratory Disease Treatment Market Analysis and Forecast
13.1. Key Findings
13.2. Policies and Regulations
13.3. Market Size (US$ Mn) Forecast, Disease Type,
13.3.1. Upper Respiratory Tract Infections
13.3.2. Diphtheria
13.3.3. Pneumonia (Lower Respiratory Tract Infection)
13.4. Market Size (US$ Mn) Forecast, Treatment Type,
13.4.1. Vaccines
13.4.2. Antibiotics
13.4.3. NSAIDs
13.4.4. Immunomodulators
13.4.5. Others
13.5. Market Size (US$ Mn) Forecast, By Distribution Channel,
13.5.1. Veterinary Hospitals
13.5.2. Veterinary Clinics
13.5.3. Private Veterinary Pharmacies
13.5.4. Veterinary Research Institutes
13.5.5. Others
13.6. Market Size (US$ Mn) Forecast, By Country
13.6.1. South Africa
13.6.2. Saudi Arabia
13.6.3. UAE
13.6.4. Rest of MEA
13.7. Market Attractiveness Analysis
13.7.1. By Country
13.7.2. Disease Type
13.7.3. By Treatment Type
13.7.4. By Distribution Channel
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis By Company (2015)
14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.3.1. Global Market Players
14.3.1.1. Merck & Co., Inc.
14.3.1.1.1. Company Overview
14.3.1.1.2. Financial Overview
14.3.1.1.3. Product Portfolio
14.3.1.1.4. Business Strategies
14.3.1.1.5. Recent Developments
14.3.1.2. Zoetis Services LLC
14.3.1.2.1. Company Overview
14.3.1.2.2. Financial Overview
14.3.1.2.3. Product Portfolio
14.3.1.2.4. Business Strategies
14.3.1.2.5. Recent Developments
14.3.1.3. Bayer AG
14.3.1.3.1. Company Overview
14.3.1.3.2. Financial Overview
14.3.1.3.3. Product Portfolio
14.3.1.3.4. Business Strategies
14.3.1.3.5. Recent Developments
14.3.1.4. Elanco
14.3.1.4.1. Company Overview
14.3.1.4.2. Financial Overview
14.3.1.4.3. Product Portfolio
14.3.1.4.4. Business Strategies
14.3.1.4.5. Recent Developments
14.3.1.5. Merial
14.3.1.5.1. Company Overview
14.3.1.5.2. Financial Overview
14.3.1.5.3. Product Portfolio
14.3.1.5.4. Business Strategies
14.3.1.5.5. Recent Developments
14.3.1.6. Boehringer Ingelheim GmbH
14.3.1.6.1. Company Overview
14.3.1.6.2. Financial Overview
14.3.1.6.3. Product Portfolio
14.3.1.6.4. Business Strategies
14.3.1.6.5. Recent Developments
14.3.1.7. Virbac Group
14.3.1.7.1. Company Overview
14.3.1.7.2. Financial Overview
14.3.1.7.3. Product Portfolio
14.3.1.7.4. Business Strategies
14.3.1.7.5. Recent Developments
14.3.1.8. Ceva
14.3.1.8.1. Company Overview
14.3.1.8.2. Financial Overview
14.3.1.8.3. Product Portfolio
14.3.1.8.4. Business Strategies
14.3.1.8.5. Recent Developments
14.3.1.9. Vetoquinol
14.3.1.9.1. Company Overview
14.3.1.9.2. Financial Overview
14.3.1.9.3. Product Portfolio
14.3.1.9.4. Business Strategies
14.3.1.9.5. Recent Developments
14.3.1.10. Bimeda animal health
14.3.1.10.1. Company Overview
14.3.1.10.2. Financial Overview
14.3.1.10.3. Product Portfolio
14.3.1.10.4. Business Strategies
14.3.1.10.5. Recent Developments
List of Tables
Table 01: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 02: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 03: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 04: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 05: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 06: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 07: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 08: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 09: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 10: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 11: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 12: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 13: Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 14: Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 15: Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 16: Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 17: Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 18: Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 19: Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 20: Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 21: Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 22: Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 23: Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 24: Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 01: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 02: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 03: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 04: Global Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 05: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 06: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 07: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 08: North America Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 09: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Disease Type, 2014–2024
Table 10: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2014–2024
Table 11: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 12: Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, by Country, 2014–2024
List of Figures
Figure 01: Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, 2014–2024
Figure 02: Bovine Respiratory Disease Treatment Average Price (US$/ Treatment Type) 2014–2024
Figure 03: Market Value Share (%), by Disease Type (2015)
Figure 04: Market Value Share (%), by Treatment Type (2015)
Figure 05: Market Value Share (%), by End-user (2015)
Figure 06: Market Value Share (%), by Region (2015)
Figure 07: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Disease Type, 2015 and 2024
Figure 08: Global Upper Respiratory Tract Infections Market Size (US$ Mn), 2014–2024
Figure 09: Global Diphtheria Market Size (US$ Mn), 2014–2024
Figure 10: Global Pneumonia (lower respiratory tract infection) Market Size (US$ Mn), 2014–2024
Figure 11: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Disease Type, 2015
Figure 12: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Treatment Type, 2015 and 2024
Figure 13: Global Vaccines Market Size (US$ Mn), 2014–2024
Figure 14: Global Antibiotics Market Size (US$ Mn), 2014–2024
Figure 15: Global NSAIDs Market Size (US$ Mn), 2014–2024
Figure 16: Global Immunomodulators Market Size (US$ Mn), 2014–2024
Figure 17: Global Others Market Size (US$ Mn), 2014–2024
Figure 18: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Treatment Type, 2015
Figure 19: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 20: Global Veterinary Hospitals Market Size (US$ Mn), 2014–2024
Figure 21: Global Veterinary Clinics Market Size (US$ Mn), 2014–2024
Figure 22: Global Private Veterinary Pharmacies Market Size (US$ Mn), 2014–2024
Figure 23: Global Veterinary Research Institutes Market Size (US$ Mn), 2014–2024
Figure 24: Global Others Market Size (US$ Mn), 2014–2024
Figure 25: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 26: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Region, 2015 and 2024
Figure 27: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Region, 2015
Figure 28: U.S. Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 29: Canada Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 30: North America Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 31: North America Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 32: North America Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 33: North America Market Attractiveness Analysis, by Country, 2014–2024
Figure 34: Germany Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 35: U.K. Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 36: France Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 37: Spain Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 38: Italy Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 39: Rest of Europe Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 40: Europe Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 41: Europe Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 42: Europe Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 43: Europe Market Attractiveness Analysis, by Country, 2014–2024
Figure 44: Japan Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 45: China Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 46: India Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 47: Australia Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 48: Rest of Asia Pacific Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 49: Asia Pacific Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 50: Asia Pacific Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 51: Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 52: Asia Pacific Market Attractiveness Analysis, by Country, 2014–2024
Figure 53: Brazil Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 54: Mexico Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 55: Rest of Latin America Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 56: Latin America Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 57: Latin America Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 58: Latin America Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 59: Latin America Market Attractiveness Analysis, by Country, 2014–2024
Figure 60: South Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 61: UAE Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 62: Rest of Middle East & Africa Bovine Respiratory Disease Treatment Market Size (US$ Mn), 2014–2024
Figure 63: Middle East & Africa Market Attractiveness Analysis, by Treatment Type, 2014–2024
Figure 64: Middle East & Africa Market Attractiveness Analysis, by Disease Type, 2014–2024
Figure 65: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 66: Middle East & Africa Market Attractiveness Analysis, by Country, 2014–2024
Figure 01: Bovine Respiratory Disease Treatment Market Size (US$ Mn) Forecast, 2014–2024
Figure 02: Bovine Respiratory Disease Treatment Average Price (US$/ Treatment Type) 2014–2024
Figure 03: Market Value Share (%), by Disease Type (2015)
Figure 04: Market Value Share (%), by Treatment Type (2015)
Figure 05: Market Value Share (%), by End-user (2015)
Figure 06: Market Value Share (%), by Region (2015)
Figure 07: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Disease Type, 2015 and 2024
Figure 08: Global Upper Respiratory Tract Infections Market Size (US$ Mn), 2014–2024
Figure 09: Global Diphtheria Market Size (US$ Mn), 2014–2024
Figure 10: Global Pneumonia (lower respiratory tract infection) Market Size (US$ Mn), 2014–2024
Figure 11: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Disease Type, 2015
Figure 12: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Treatment Type, 2015 and 2024
Figure 13: Global Vaccines Market Size (US$ Mn), 2014–2024
Figure 14: Global Antibiotics Market Size (US$ Mn), 2014–2024
Figure 15: Global NSAIDs Market Size (US$ Mn), 2014–2024
Figure 16: Global Immunomodulators Market Size (US$ Mn), 2014–2024
Figure 17: Global Others Market Size (US$ Mn), 2014–2024
Figure 18: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Treatment Type, 2015
Figure 19: Global Bovine Respiratory Disease Treatment Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 20: Global Veterinary Hospitals Market Size (US$ Mn), 2014–2024
Figure 21: Global Veterinary Clinics Market Size (US$ Mn), 2014–2024
Figure 22: Global Private Veterinary Pharmacies Market Size (US$ Mn), 2014–2024
Figure 23: Global Veterinary Research Institutes Market Size (US$ Mn), 2014–2024
Figure 24: Global Others Market Size (US$ Mn), 2014–2024
Figure 25: Bovine Respiratory Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2015
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Bovine Respiratory Disease Treatment Market
